No Data
Earnings Preview: SAGE to Report Financial Results Post-market on October 29
$Sage Therapeutics(SAGE.US)$ is scheduled to release its financial results post-market on October 29 ET. Earnings PreviewAnalysts estimate $Sage Therapeutics(SAGE.US)$ to post revenue of USD11.12M
TD Cowen Maintains Sage Therapeutics(SAGE.US) With Hold Rating, Maintains Target Price $10
State Street Corp's Strategic Acquisition of Sage Therapeutics Shares
Scotiabank Maintains Sage Therapeutics(SAGE.US) With Buy Rating, Maintains Target Price $17
Scotiabank Reaffirms Their Buy Rating on SAGE Therapeutics (SAGE)
Needham Maintains Sage Therapeutics(SAGE.US) With Hold Rating